Indefinite Delivery Contract 223032480

Award Date 5/20/03
Last Date to Order 8/22/08
Ultimate Awardee
Not listed
NAICS Category
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The FDA has awarded Eurofins Panlabs, Inc., a foreign-owned for-profit contract research organization, a single-award indefinite delivery contract (IDC) worth up to $20 million for research and development services and studies through September 2028. Under this IDC, Eurofins Panlabs provides non-clinical and laboratory support services such as analytical chemistry, microbiology, and toxicology testing to support the discovery and development of drug candidates. This includes evaluating the...
The summary is as follows: The Department of Health and Human Services' Food and Drug Administration (FDA) has awarded an Indefinite Delivery Contract (IDC) worth up to $10 million to Molecular Epidemiology Inc., a for-profit, woman-owned small business. The contract is for microbiological analysis of FDA-regulated foods, agricultural water, and cosmetics. This includes tasks such as whole genome sequencing, pathogen testing, and epidemiological assessments to support the FDA's food safety and...
This indefinite delivery contract was awarded by a civilian federal agency to Labcorp Early Development Laboratories Inc., a subsidiary of Laboratory Corporation of America Holdings, to provide a range of laboratory testing and analytical services. The contract, which has a ceiling value of $2,530,101.01, is not set aside for small businesses. Through this contract, Labcorp Early Development Laboratories Inc. has performed stability testing, potency and safety assays, polyclonal antibody...
The Environmental Protection Agency (EPA) awarded Eurofins Panlabs, Inc., a foreign-owned, for-profit contract research organization, a single-award indefinite delivery contract (IDC) worth up to $9.7 million to provide confirmatory assays, safety pharmacology services, and research and development products. This contract supports the EPA's efforts to identify chemical mechanisms of action and assess risks through in vitro and target-based studies. Under this IDC, the EPA has issued multiple...
The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Propharma Group, LLC (doing business as Acadeus) with a potential value of $25 million. The contract provides review of Laboratory-Developed Tests and In Vitro Diagnostics Support through March 6, 2027. A $7.736 million firm fixed price delivery order was also awarded for the period of March 2, 2022 through September 6, 2024 in Silver Spring, Maryland. Under this delivery order,...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency of the U.S. government. The contract was awarded to Advanced Bioscience Laboratories, Inc. (ABL), a foreign-owned, for-profit manufacturer of goods specializing in biopharmaceutical research and development. The IDC, valued at a ceiling of $48,882,666, covers a broad range of pharmacology studies, animal model development, and...
This federal contract indefinite delivery vehicle (IDV) was awarded by the Department of Health and Human Services' Food and Drug Administration (FDA) to Molecular Epidemiology Inc., a for-profit, woman-owned small business. The single-award contract, valued at up to $10 million, is for microbiological analysis and whole genome sequencing of FDA-regulated food products, agricultural water, and cosmetic samples to support the FDA's food safety and public health missions. Under this IDV, the FDA...
The key products and services being delivered under this federal Indefinite Delivery Contract (IDC) award include professional and technical services to support federal agencies, particularly the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC). The prime contractor, Eagle Global Scientific LLC, is an Alaskan Native Corporation-owned small business that has been awarded numerous delivery orders and contracts to provide comprehensive...
This federal Indefinite Delivery Contract (IDC) was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Idexx Distribution, Inc., a subsidiary of Idexx Laboratories, Inc. The $1,830,828 single-award IDC is for the provision of laboratory animal diagnostic testing services to support NIEHS research requirements through July 2029. The contract does not have a set-aside designation, indicating Idexx...
The Food and Drug Administration awarded a single award indefinite delivery contract to Laboratory Corporation of America Holdings to provide COVID-19 testing services. Under the contract, two firm fixed price delivery orders were issued for a total value of $206,037. The first order is for testing 2,500 FDA Office of Regulatory Affairs employees for $190,775. The second order is for testing 200 Center for Tobacco Products personnel for $15,262. Both delivery orders have a period of...
  • 223032480
    Indefinite Delivery Contract
  • 26
    Federal Contract Awards

This indefinite delivery contract was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization. The contract, valued at up to $316,840.39, is for pathology support services and does not have a set-aside designation. EPL, which is registered in the System for Award Management (SAM) through January 2026, has extensive experience providing specialized scientific and laboratory services to multiple government agencies, including the Environmental Protection Agency (EPA), Centers for Disease Control and Prevention (CDC), and National Institutes of Health (NIH).

The contracted work primarily involves histological examination, microscopic tissue evaluation, pathology reporting, and specialized studies using rodent and human tissue samples. Recent task orders have focused on areas such as perfluoroalkyl substances (PFAS) exposure studies, COVID-19 related histological research, toxicology evaluations, and environmental impact assessments. The contract has a base period of performance from May 2003 to August 2008, with multiple firm fixed-price task orders issued during that time for various pathology support services to be performed at locations in Virginia, Maryland, and Washington, D.C.

Generated 4/27/25, 12:57 AM